Affiliations 

  • 1 Perlmutter Cancer Center, Section for Global Health, Division of Health and Behavior, Department of Population Health, New York University Langone Health, New York, New York
  • 2 Department of Surgery, Faculty of Medicine, University of Malaya, Kuala Lumpur, Malaysia
  • 3 Department of Surgery, University of Pennsylvania, Philadelphia, Pennsylvania
  • 4 The Susan G. Komen Foundation, Washington, District of Columbia
  • 5 Breast Center, Moinhos de Vento Hospital, Porto Alegre, Brazil
  • 6 Department of Breast, Skin, and Soft Tissue Sarcomas Surgery, National Institute of Neoplastic Diseases, Lima, Peru
  • 7 Department of Oncology, Department of Public Health Sciences and Division of Cancer Care and Epidemiology, Queen's University, Kingston, Ontario, Canada
  • 8 International Agency for Research on Cancer, Lyon, France
  • 9 Department of Nursing, University of Panama, Panama City, Panama
  • 10 India Cancer Research Consortium, Delhi, India
  • 11 Unit for Biomedical Cancer Research, National Cancer Institute, National Autonomous University of Mexico, Mexico City, Mexico
  • 12 Xavierian University Oncology Center, San Ignacio University Hospital, Bogota, Colombia
  • 13 Division of Women's Health, Department of Medicine, Brigham and Women's Hospital, Boston, Massachusetts
  • 14 Department of Internal Medicine, College of Medicine, The Ohio State University, Columbus, Ohio
  • 15 Breast Surgery, Dubin Breast Center, The Icahn School of Medicine at The Mount Sinai Hospital, New York, New York
  • 16 Department of Epidemiology, Johns Hopkins Bloomberg School of Public Health, Baltimore, Maryland
  • 17 Department of Radiology, University of Washington, Seattle, Washington
  • 18 Health, Nutrition, and Population Global Practice, The World Bank Group, Washington, District of Columbia
  • 19 CONACYT Fellow, National Cancer Institute, Mexico City, Mexico
  • 20 National Center for Oncology, Radiotherapy, and Nuclear Medicine, Accra, Ghana
  • 21 Center for Health Disparities Innovation and Studies, Eastern Michigan University, Ypsilanti, Michigan
  • 22 Reproductive and Child Health Section, Ministry of Health, Community, Ministry of Health, Community Development, Development Gender, Elderly, and Children Dodoma, Children Dodoma, Tanzania
  • 23 Breast Health Global Initiative, Fred Hutchinson Cancer Research Center, Seattle, Washington
  • 24 Department of Global Health, University of Washington, Seattle, Washington
Cancer, 2020 May 15;126 Suppl 10(Suppl 10):2379-2393.
PMID: 32348566 DOI: 10.1002/cncr.32887

Abstract

When breast cancer is detected and treated early, the chances of survival are very high. However, women in many settings face complex barriers to early detection, including social, economic, geographic, and other interrelated factors, which can limit their access to timely, affordable, and effective breast health care services. Previously, the Breast Health Global Initiative (BHGI) developed resource-stratified guidelines for the early detection and diagnosis of breast cancer. In this consensus article from the sixth BHGI Global Summit held in October 2018, the authors describe phases of early detection program development, beginning with management strategies required for the diagnosis of clinically detectable disease based on awareness education and technical training, history and physical examination, and accurate tissue diagnosis. The core issues address include finance and governance, which pertain to successful planning, implementation, and the iterative process of program improvement and are needed for a breast cancer early detection program to succeed in any resource setting. Examples are presented of implementation, process, and clinical outcome metrics that assist in program implementation monitoring. Country case examples are presented to highlight the challenges and opportunities of implementing successful breast cancer early detection programs, and the complex interplay of barriers and facilitators to achieving early detection for breast cancer in real-world settings are considered.

* Title and MeSH Headings from MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.